Icure Pharmaceuticals Private Limited
About Icure Pharmaceuticals Private Limited
Data last updated:
Icure Pharmaceuticals Private Limited is a private limited company based in Guntur, Andhra Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 29 November 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Vijayawada, under CIN U24304AP2019PTC113537. Its GSTIN is 37AAFCI4870A1ZQ (Andhra Pradesh).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Brahmareddy Pasam and Pasam Swetha Reddy.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No 301 Ecopride Apartment Beside Rtc Colony, Guntur, Andhra Pradesh, India – 522001.
As per the financials filed for FY 2025, the company reported a revenue of ₹11.01 Lakh, a decline of 84% compared to the previous year. For the same year it recorded a net loss of ₹73,000 (net margin -6.6%) and EBITDA of -₹70,000 (EBITDA margin -6.4%). Revenue has declined at a compounded annual rate (CAGR) of 40% over three years.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressFlat No 301 Ecopride Apartment Beside Rtc Colony, Guntur, Andhra Pradesh, India – 522001
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Icure Pharmaceuticals Private Limited
The main business activity of Icure Pharmaceuticals is manufacturing. In detail, this covers other manufacturing.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | 32 | Other manufacturing | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Icure Pharmaceuticals Private Limited FY 2025 filings available
Icure Pharmaceuticals Private Limited reported revenue of ₹11.01 Lakh (down 84% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Icure Pharmaceuticals Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 40% over three years, including a 84% fall in the latest year. EBITDA fell 126% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Icure Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹70,000 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹73,000 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Icure Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -6.4% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -6.6% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Icure Pharmaceuticals are in the company report.
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Icure Pharmaceuticals Private Limited
Icure Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| HCLK Pharmaceuticals Private Limited | ₹11.11 Lakh (FY 2025) | •••• | •••• | 19.0% | •••• | Delhi, India |
| Medsci Pharmaceuticals Private Limited | ₹11.11 Lakh (FY 2025) | •••• | •••• | •••• | Varanasi, Uttar Pradesh, India | |
| Medbro 5 India Pharmaceuticals Private Limited | ₹11.04 Lakh (FY 2025) | •••• | •••• | -21.0% | •••• | Pune, Maharashtra, India |
| Utrint Pharmaceuticals Private Limited | ₹11.03 Lakh (FY 2025) | •••• | •••• | 21.0% | •••• | Beed, Maharashtra, India |
| Avendus Pharmaceuticals Private Limited | ₹11.01 Lakh (FY 2023) | •••• | •••• | -57.0% | •••• | Nashik, Maharashtra, India |
| Icure Pharmaceuticals Private Limited this company | ₹11.01 Lakh (FY 2025) | •••• | •••• | -84.0% | •••• | Guntur, Andhra Pradesh, India |
| Indoraggu Pharmaceuticals Private Limited | ₹11 Lakh (FY 2024) | •••• | •••• | -45.0% | •••• | Mysore, Karnataka, India |
| BTL Pharmaceuticals Private Limited | ₹10.97 Lakh (FY 2024) | •••• | •••• | -15.0% | •••• | Chennai, Tamil Nadu, India |
| Unihex Pharmaceuticals Private Limited | ₹10.96 Lakh (FY 2022) | •••• | •••• | 45.0% | •••• | Hyderabad, Telangana, India |
| Davion Pharmaceuticals (P) Ltd. | ₹10.93 Lakh (FY 2022) | •••• | •••• | -42.0% | •••• | Agra, Uttar Pradesh, India |
| Kmedlan Pharmaceuticals Private Limited | ₹10.92 Lakh (FY 2022) | •••• | •••• | •••• | Bilaspur, Chhattisgarh, India |
Peers are the five companies nearest above and the five nearest below Icure Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Icure Pharmaceuticals Private Limited
Icure Pharmaceuticals Private Limited is audited by PHANIINDRA & CO for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| PHANIINDRA & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Icure Pharmaceuticals Private Limited
Icure Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Brahmareddy Pasam | Director | 29 Nov 2019 | 6 Years 10 Months | Current |
| Pasam Swetha Reddy | Additional Director | 17 Feb 2026 | 0 Years 7 Months | Current |
Ownership and Shareholding of Icure Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Icure Pharmaceuticals Private Limited
Icure Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Icure Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Icure Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Icure Pharmaceuticals Private Limited
Icure Pharmaceuticals Private Limited has 3 board changes on record since 2019: 3 appointments. The latest: Pasam Swetha Reddy was appointed as Additional Director on 17 Feb 2026.
Credit Ratings, Litigation & Regulatory Alerts for Icure Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Icure Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Icure Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Icure Pharmaceuticals Private Limited
Icure Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 37AAFCI4870A1ZQ | Andhra Pradesh | Active | 10 Feb 2020 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Icure Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Icure Pharmaceuticals Private Limited
Icure Pharmaceuticals is an active private limited company based in Guntur, Andhra Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 29 November 2019 (7+ years old) and is registered under CIN U24304AP2019PTC113537.
Icure Pharmaceuticals reported revenue of ₹11.01 Lakh for FY 2025 (down 84% YoY).
Icure Pharmaceuticals has 2 current directors:
- Brahmareddy Pasam - Director
- Pasam Swetha Reddy - Additional Director
Icure Pharmaceuticals reported a net loss of ₹73,000 (net margin -6.6%) and EBITDA of -₹70,000 (EBITDA margin -6.4%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Icure Pharmaceuticals is -40% over three years. In the latest year (FY 2025) revenue fell 84%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Icure Pharmaceuticals is 37AAFCI4870A1ZQ, registered in Andhra Pradesh.
The CIN (Corporate Identification Number) of Icure Pharmaceuticals is U24304AP2019PTC113537. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Icure Pharmaceuticals was incorporated on 29 November 2019, making it 7+ years old. It is registered with the Registrar of Companies, Vijayawada.
The peers of Icure Pharmaceuticals by revenue are HCLK Pharmaceuticals Private Limited, Medsci Pharmaceuticals Private Limited, Medbro 5 India Pharmaceuticals Private Limited, Utrint Pharmaceuticals Private Limited, Avendus Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Pasam Swetha Reddy was appointed as Additional Director on 17 Feb 2026. Ashok Reddy Sirigiri was appointed as Director on 29 Nov 2019. Brahmareddy Pasam was appointed as Director on 29 Nov 2019.
The registered office of Icure Pharmaceuticals is at Flat No 301 Ecopride Apartment Beside Rtc Colony, Guntur, Andhra Pradesh, India – 522001.